Edwards' EVOQUE Valve Replacement System First Transcatheter Therapy to Earn FDA Approval for Tricuspid ValveBusiness Wire • 02/02/24
Stay Ahead of the Game With Edwards Lifesciences (EW) Q4 Earnings: Wall Street's Insights on Key MetricsZacks Investment Research • 02/01/24
Strength Seen in Edwards Lifesciences (EW): Can Its 6.2% Jump Turn into More Strength?Zacks Investment Research • 02/01/24
Edwards Lifesciences to Present at the 42nd Annual J.P. Morgan Healthcare ConferenceBusiness Wire • 01/02/24
Edwards Lifesciences (EW) Up 6.8% Since Last Earnings Report: Can It Continue?Zacks Investment Research • 11/24/23
CLASP IID ONE-YEAR DATA CONFIRM SAFETY AND EFFICACY OF EDWARDS PASCAL SYSTEM FOR DEGENERATIVE MITRAL REGURGITATIONPRNewsWire • 10/26/23
TRISCEND II SIX-MONTH DATA FOR FIRST 150 PATIENTS SUCCESSFULLY DEMONSTRATE SAFETY AND EFFICACY OF EDWARDS EVOQUE SYSTEM FOR SEVERE TRICUSPID REGURGITATIONPRNewsWire • 10/26/23
Edwards Lifesciences (EW) Reports Q3 Earnings: What Key Metrics Have to SayZacks Investment Research • 10/25/23